<?xml version="1.0" encoding="ISO-8859-1"?>
<entity-relation-data lastUpdate="2023-03-27 16:27:52" record="13670" source="Espacenet">
	<entities>
		<entity ref="Patent13670" type="Patent">
			<semanticIdentifier>brcris::47d4374fdb84d228871b351c8c733ea4</semanticIdentifier>
			<semanticIdentifier>docdb::BR102017024448A2</semanticIdentifier>
			<semanticIdentifier>epodoc::BR102017024448</semanticIdentifier>
			<semanticIdentifier>docdb::BR102017024448A</semanticIdentifier>
			<semanticIdentifier>epodoc::BR20171024448</semanticIdentifier>
			<semanticIdentifier>original::102017024448</semanticIdentifier>
			<field name="urlEspacenet" value="https://worldwide.espacenet.com/patent/search?q=102017024448"/>
			<field name="identifier.lattes" value="2355630416880005"/>
			<field name="identifier.espacenet" value="102017024448"/>
			<field name="kindCode" value="A2"/>
			<field name="title.espacenet" value="composição e método de produção de sistemas nanoparticulados para liberação modificada de benznidazol"/>
			<field name="title.lattes" value="COMPOSIÇÃO E MÉTODO DE PRODUÇÃO DE SISTEMAS NANOPARTICULADOS PARA A LIBERAÇÃO MODIFICADA DE BENZNIDAZOL"/>
			<field name="depositDate" value="2017-11-14"/>
			<field name="publicationDate" value="2019-06-04"/>
			<field name="countryCode" value="BR"/>
			<field name="inventor" value="ALAINE MARIA DOS SANTOS SILVA"/>
			<field name="inventor" value="ARNOBIO ANTONIO DA SILVA JUNIOR"/>
			<field name="inventor" value="EMANUELL DOS SANTOS SILVA"/>
			<field name="inventor" value="LANNYA CLARA SANTOS TAVARES PESSOA"/>
			<field name="applicant" value="UNIVERSIDADE FEDERAL DO RIO GRANDE DO NORTE"/>
			<field name="classification.ipc">
				<field name="sequence" value="1"/>
				<field name="text" value="A61K9/26AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="K"/>
				<field name="group" value="9"/>
				<field name="subgroup" value="26AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="2"/>
				<field name="text" value="A61K9/51AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="K"/>
				<field name="group" value="9"/>
				<field name="subgroup" value="51AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="3"/>
				<field name="text" value="A61K31/4168AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="K"/>
				<field name="group" value="31"/>
				<field name="subgroup" value="4168AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="4"/>
				<field name="text" value="A61K47/34AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="K"/>
				<field name="group" value="47"/>
				<field name="subgroup" value="34AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="5"/>
				<field name="text" value="A61P33/02AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="P"/>
				<field name="group" value="33"/>
				<field name="subgroup" value="02AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="6"/>
				<field name="text" value="B82Y5/00AI"/>
				<field name="section" value="B"/>
				<field name="class" value="82"/>
				<field name="subclass" value="Y"/>
				<field name="group" value="5"/>
				<field name="subgroup" value="00AI"/>
			</field>
			<field name="abstract.espacenet" value="a invenção refere-se à composição e ao método de preparo de sistemas nanoparticulados para liberação modificada do benznidazol (n-benzil-2-(2-nitroimidazol-1-il) acetamida), que se apresentam em forma de nanopartículas poliméricas à base dos polímeros como derivados do ácido metacrílico (eudragit® r100, e100), poli(ácido lático) (pla), poli(ácido lático-co-glicólico) (plga) ou de lipídeos, podendo ter a superfície das partículas funcionalizada com agentes catiônicos, ácido siálico, colesterol ou outras moléculas. esses sistemas obtidos pelo método de deslocamento de solvente/nanoprecipitação e/ou emulsificação com evaporação do solvente, de modo a possibilitar a administração oral e/ou parenteral, modificando a biodisponibilidade do fármaco em relação às formas de administração disponíveis, sendo eficiente para o tratamento na fase crônica da doença de chagas que permita ultrapassar barreiras biológicas naturais, as quais agem no direcionamento do fármaco para as células infectadas e/ou para o parasita."/>
			<field name="originatesFrom" value="67260702"/>
			<field name="alternateIdentifier">
				<field name="status" value="Publication"/>
				<field name="format" value="docdb"/>
				<field name="country" value="BR"/>
				<field name="number" value="102017024448"/>
				<field name="kind" value="A2"/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Publication"/>
				<field name="format" value="epodoc"/>
				<field name="country" value="BR"/>
				<field name="number" value="BR102017024448"/>
				<field name="kind" value=""/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="docdb"/>
				<field name="country" value="BR"/>
				<field name="number" value="102017024448"/>
				<field name="kind" value="A"/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="epodoc"/>
				<field name="country" value="BR"/>
				<field name="number" value="BR20171024448"/>
				<field name="kind" value=""/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="original"/>
				<field name="country" value=""/>
				<field name="number" value="102017024448"/>
				<field name="kind" value=""/>
			</field>
		</entity>
		<entity ref="Person9395" type="Person">
			<semanticIdentifier>lattes::2355630416880005</semanticIdentifier>
			<field name="identifier.lattes" value="2355630416880005"/>
			<field name="name" value="Emanuell dos Santos Silva"/>
		</entity>
		<entity ref="OrgUnit7391" type="OrgUnit">
			<semanticIdentifier>brcris::45080c382105e5df08efa0a521074fd3</semanticIdentifier>
			<field name="name" value="UNIVERSIDADE FEDERAL DO RIO GRANDE DO NORTE"/>
		</entity>
	</entities>
	<relations>
		<relation fromEntityRef="Patent13670" toEntityRef="Person9395" type="Inventor"/>
		<relation fromEntityRef="Patent13670" toEntityRef="OrgUnit7391" type="Applicant"/>
	</relations>
</entity-relation-data>
